The number of tumor-infiltrating B cells and tumor PRELP expression were associated with a decreased risk of skin cutaneous melanoma (HR = − 2.533; p = 2.81E−02), which was not significant for metastatic melanoma (HR = − 1.995; p = 1.25E−01). The gene discussed is PRELP; the disease is cutaneous melanoma.